Sector
Pharma VC Funds
Venture capital funds investing in pharmaceutical development, drug discovery, and clinical-stage biotech companies.
FLEX Capital is a Berlin-based private equity firm that focuses on acquiring and scaling medium-sized software and tech companies in the DACH region (Germany, Austria, and Switzerland). Founded by a team of experienced entrepreneurs and investors, FLEX Capital specializes in businesses generating between €5 million to €30 million in annual revenue. Their strategy revolves around supporting profitable, growing companies with operational expertise and capital, helping them scale to the next level of growth. Recently, FLEX Capital closed a €300 million fund to expand its portfolio, which includes companies like Nitrado (a global leader in multiplayer game hosting), ComX (a B2B sales enablement platform), and the EVEX Group, which provides software solutions for the healthcare sector. The firm takes an active role in its portfolio companies, leveraging its 30-person team of experts to provide operational support in areas like strategy, growth, and digital transformation. The firm’s leadership, including managing partners Peter Waleczek and Christoph Jost, has a strong track record in entrepreneurship and consulting, enabling them to provide hands-on guidance to their portfolio companies. This makes FLEX Capital a valuable partner for mid-sized tech companies looking to accelerate their growth and navigate complex market challenges.
Flint Capital is an international venture capital firm established in 2013, headquartered in Boston with offices in Tel Aviv and Palo Alto. The firm focuses on early-stage technology-driven companies across the US, Europe, and Israel. Flint Capital’s notable investments include Socure, WalkMe, Flo, Antidote Health, and CyberX. Their portfolio spans various sectors such as AI, health tech, fintech, and enterprise software. Flint Capital employs a “bridge” strategy, supporting startups in expanding to the US and other global markets. This approach leverages their extensive network of entrepreneurs, industry experts, and investment funds. Typically, Flint Capital invests between $0.5 to $3 million in early-stage companies, with a preference for leading seed, Series A, and Series B rounds. The investment team includes General Partners Dmitry Smirnov, Sergey Gribov, and Andrew Gershfeld. The firm’s funds have shown strong performance, with their first fund being among the top 10% of venture funds globally by TVPI. Flint Capital is known for its active involvement in guiding portfolio companies, providing support in business development, strategic partnerships, and more.
Floodgate is a prominent venture capital firm based in Palo Alto, California, co-founded by Mike Maples Jr. and Ann Miura-Ko in 2010. The firm focuses on early-stage investments in technology companies, particularly in Silicon Valley. With a keen eye for disruptive innovations, Floodgate has made significant investments in companies like Twitter, Lyft, Twitch, Okta, Chegg, and Clover Health. Floodgate is known for its “Thunder Lizards” concept, which describes companies with the potential to become wildly disruptive market leaders. This idea, coined by Mike Maples Jr., reflects Floodgate's strategy of identifying and supporting transformative startups from the earliest stages. They typically invest between $150,000 and $1 million, often leading seed rounds and providing extensive support and guidance to their portfolio companies. Ann Miura-Ko, a highly respected figure in the venture capital world, has been instrumental in shaping Floodgate’s investment philosophy. She has been recognized multiple times on Forbes' Midas List and the New York Times' top venture capitalists list. Her investments span across a range of sectors, including marketplaces and highly technical fields, making her a versatile and visionary investor. Floodgate's investment approach is characterized by a deep commitment to its portfolio companies, offering not just capital but also strategic advice and operational support. The firm's focus on fostering long-term relationships with founders and helping them navigate the complexities of scaling their businesses has contributed to its success and reputation in the venture capital industry.
Flucas Ventures, founded by Ashley Flucas, is a venture capital firm that focuses on early-stage investments in a diverse range of sectors, including SaaS, AI, fintech, mobile, IoT, and more. Based in West Palm Beach, Florida, the firm operates on a global scale, investing in innovative startups that are reshaping industries. The firm has built an impressive portfolio featuring companies like Databricks, Brex, Axiom Space, and GrubMarket. Flucas Ventures is sector-agnostic and stage-agnostic, investing in opportunities from pre-seed to growth stages. Flucas Ventures is also committed to promoting diversity within the venture capital space. Ashley Flucas actively invites a diverse group of investors to participate in her syndicate, providing access to top-tier deals that were traditionally less accessible. This approach aims to diversify the pool of investors and empower a broader range of individuals to create wealth through venture capital. The firm has made over 275 investments, reflecting a robust and diverse investment strategy. By focusing on both financial returns and social impact, Flucas Ventures stands out as a progressive and inclusive player in the venture capital industry.
Fly Ventures, founded in 2015, is an early-stage venture capital firm based in Berlin, with offices in London, Paris, and Zurich. The firm focuses on investing in deep tech and software-driven startups, primarily backing technical founders who are solving complex problems from day zero through to seed stage. Fly Ventures takes a hands-on approach, offering not only capital but also strategic support to help startups grow globally. The firm’s portfolio features innovative companies across sectors like AI, healthcare, cybersecurity, and developer tools. Notable investments include Orbital Materials, which leverages AI for material discovery, Evidently AI, an open-source tool for monitoring machine learning models, and GitButler, which redefines source code management with AI-driven automation. Fly Ventures emphasizes building long-term partnerships with startups, helping them secure follow-on funding, often from tier-one European or U.S. VCs. Over 60% of their portfolio companies have gone on to raise additional funding from top investors. Led by partners like Gabriel Matuschka, Fredrik Bergenlid, and Marie Brayer, Fly Ventures prides itself on identifying high-potential startups across Europe. The firm is also supported by InnovFin Equity and the European Fund for Strategic Investments, highlighting its commitment to driving innovation and growth in the European tech ecosystem.
FootPrint Coalition, founded by Robert Downey Jr. in 2019, is a venture capital firm with a mission to drive innovation in sustainability. The coalition operates through three key areas: venture investments, scientific research funding, and media advocacy. Its VC arm, FootPrint Coalition Ventures, launched in 2021, focuses on investing in climate tech startups that are working on solutions in fields like food and agriculture, energy, transportation, and carbon removal. The firm has backed companies like Commonwealth Fusion Systems, which aims to produce emission-free electricity through fusion, and RWDC Industries, a biotech company creating biodegradable alternatives to single-use plastics. FootPrint Coalition's non-profit "science engine" provides fast grants to support cutting-edge environmental research, particularly in high-risk, high-reward areas that might struggle to secure traditional funding. Projects funded by this initiative span fields like conservation biotechnology and cellular agriculture. Through its media arm, FootPrint Coalition amplifies the impact of these technologies, using storytelling to engage a broad audience. By leveraging Robert Downey Jr.'s platform, the coalition educates the public about climate innovations and promotes sustainable solutions globally. With over 26 investments to date, including companies like Aspiration Bank and Wildtype, FootPrint Coalition is dedicated to advancing a greener future.
Footwork is an early-stage venture capital firm based in San Francisco, co-founded by Mike Smith and Nikhil Basu Trivedi in 2021. The firm focuses on Seed and Series A investments in consumer technology and the consumerization of enterprise technology, aiming to support startups with early signs of product-market fit. Footwork's investment strategy is centered on leading or co-leading funding rounds in promising early-stage companies. They prioritize founders who are building category-defining companies in sectors like enterprise applications, health tech, and sustainability. The firm has a particular interest in companies that blend consumer and enterprise tech, a reflection of the founders' backgrounds at Stitch Fix and Shasta Ventures. Since its inception, Footwork has invested in several innovative startups, including Cradlewise, GPTZero, and WindBorne Systems. They typically target investments in the U.S. but have also backed companies in other regions, like New Zealand. Their portfolio is designed with a high-conviction approach, meaning they focus on a smaller number of investments where they believe they can make a significant impact.
Forbion, a venture capital firm based in the Netherlands, specializes in investing in life sciences companies. Founded in 2006, Forbion focuses on drug development, medical devices, and diagnostics, addressing high medical needs. The firm has raised significant funds, including €190 million for its FCF I Co-Invest Fund and FCF II, targeting private companies primarily in Europe, with additional investments in North America and Israel. Forbion's notable portfolio companies include Replimune, a leader in oncolytic immunotherapies, and Gyroscope Therapeutics, which was acquired by Novartis. The firm has a strong track record with successful exits, such as the sale of Fovea Pharmaceuticals to Sanofi-Aventis and the acquisition of PanGenetics by Abbott. The firm is led by Managing Partner Bart Bergstein and has expanded its European presence with offices in Naarden and Munich. Forbion's investment strategy focuses on creating value through active involvement and leading investment syndicates in the life sciences sector.
Force Over Mass Capital, also known as FOMCAP, is a venture capital firm based in London, UK, founded in 2013. The firm focuses on early-stage investments, particularly in B2B technology sectors such as fintech, AI, SaaS, and deep tech. With a strong emphasis on leveraging technology and data analytics, FOMCAP supports innovative startups across the UK and Europe. Notable investments from FOMCAP include companies like Weavr, a financial software platform; Banxware, which provides embedded financial services for small and medium-sized businesses; and Admix, a platform for monetizing virtual experiences. The firm also has investments in Dopay, a payroll solution for unbanked workers, and Adhara, which offers real-time, multi-currency liquidity management and payment solutions. FOMCAP operates several funds, including the Seed Fund, which targets early-stage B2B tech startups, and the Growth Fund, focused on growth-stage opportunities from Series A to late-stage. The firm also manages dynamically structured index funds, catering to institutional investors like pension funds. Under the leadership of Martijn De Wever, FOMCAP integrates advanced data analytics and behavioral science assessments into its investment processes, enhancing the efficiency and success rate of its portfolio companies.
orerunner Ventures is a prominent venture capital firm specializing in early-stage investments with a strong focus on consumer-centric companies. Founded in 2010 and headquartered in San Francisco, the firm is well-known for its thesis-driven approach, aiming to understand and predict consumer behavior to identify innovative businesses poised to meet evolving needs. Notable investments by Forerunner Ventures include high-profile companies such as Warby Parker, Glossier, Dollar Shave Club, and Hims. The firm also invests in fintech, marketplaces, and business-to-business solutions, with recent investments in companies like Chime, Faire, and Ampla Technologies. Ampla, for instance, provides financial solutions to SMBs, particularly minority and women-owned businesses, highlighting Forerunner's commitment to supporting diverse and inclusive entrepreneurship. Forerunner Ventures has raised significant funds, including a recent $500 million for its fifth flagship fund. The firm's investment strategy involves partnering with visionary founders from the seed stage through growth, offering not just capital but also strategic support and industry expertise to help companies scale effectively. With a robust portfolio and a focus on consumer innovation, Forerunner Ventures continues to shape the future of retail, commerce, and digital consumer experiences.
Foresight Group, established in 1984 and headquartered in London, is a leading private equity and infrastructure investment firm with a strong emphasis on sustainability and renewable energy. The firm manages over £7.2 billion in assets across various sectors, including clean energy, infrastructure, and private equity. Notable investments include Copperleaf, a business productivity software company, and several significant renewable energy projects like the Energy Works Hull and Shotwick Solar Park. Foresight Group’s strategy focuses on generating high returns through sustainable investments. They lead investment rounds and often provide substantial support and guidance to their portfolio companies. Their investments are spread across the UK, Europe, and Australia, with a notable presence in North America as well. Key team members include Tom Laidlaw (CEO), Gary Fraser (CFO), and co-founders Bernard Fairman and Peter English. The firm is highly regarded for its expertise in financial services and clean energy, having developed and managed several high-impact projects and funds, such as the Foresight Solar Fund Limited.
Foresite Capital is a leading venture capital firm based in San Francisco, specializing in healthcare and life sciences investments. Founded in 2011 by Dr. Jim Tananbaum, the firm manages around $4 billion in assets. Foresite Capital is dedicated to transforming healthcare by funding innovative companies at all stages, from early to late-stage ventures. Notable investments include high-profile companies such as 10x Genomics, Element Biosciences, Lyell Immunopharma, Inscripta, Relay Therapeutics, and GRAIL. These companies leverage cutting-edge technologies in genomics, biotech, and precision medicine to advance healthcare solutions. Foresite Capital has a track record of success with over 37 IPOs and numerous acquisitions among its portfolio companies. Foresite Capital also operates Foresite Labs, an incubator for startups at the intersection of data science and healthcare, aiming to solve critical issues in therapeutics and healthcare services. This incubator is led by Dr. Vik Bajaj, former chief scientific officer of GRAIL and co-founder of Verily (formerly Google Life Sciences).
FORM Life Ventures is a San Francisco-based healthcare venture capital firm founded in 2022, co-founded by Markus Okumus (Founding Partner) and Professor Tony Wyss-Coray (Scientific Founder), a renowned Stanford University neuroscientist known for his research on aging and blood-based biomarkers. The firm funds and incubates companies leveraging science and technology to drive the shift from traditional sickcare toward proactive, preventive healthcare. FORM Life writes first checks of $500,000 to $2 million, investing at seed and Series A stages across the US, Israel, UK, and Germany. The portfolio of six companies spans healthtech, biotech, and drug discovery. Known investments include RxDiet, an AI-driven food-as-medicine platform targeting chronic illnesses such as diabetes and hypertension, which raised a $3 million seed round in July 2024 led by Giant Ventures with FORM Life participating. The portfolio also includes Indomo, a drug discovery therapeutics company that raised $42.2 million in total from investors including Foresite Capital and Atomic14 Ventures. Other portfolio companies include Vero Bioscience, People Science, Teal Rise, and additional health platform companies. FORM Life's investment themes span e-health, medical devices, diagnostics, longevity, agetech, proteomics, digital health, mental health, connected health, and biomarker-based approaches to medicine. Professor Wyss-Coray's scientific credentials and Stanford network provide the firm with privileged access to some of the most advanced biomedical research emerging from the university, while Okumus's operational focus on company building bridges the gap between academic discovery and commercial healthcare applications.
Forward Partners is a venture capital firm based in London that specializes in early-stage investments, particularly focusing on marketplace, applied AI, and Web3 opportunities. Founded in 2013 by Nicholas Brisbourne, the firm has a strong commitment to supporting founders from the initial stages through to seed investments, providing not just capital but also operational support and expertise. The firm's notable investments include companies such as Cazoo, Juno, Patch, and Pocdoc, reflecting a diverse portfolio across various technology sectors. Forward Partners has made 119 investments to date, with significant exits like Baselime and Lexoo. Their approach is unique in that they offer "thinking capital," which helps startups not only financially but also in developing scalable products, assembling high-performing teams, and creating robust sales pipelines. Forward Partners operates with a deep understanding that succeeding in the tech industry requires more than just funding. They actively help founders navigate the complexities of building a business, leveraging their extensive network and expertise in fintech and other innovative technologies. With a presence in major tech hubs and a portfolio fair value of £80 million as of December 2022, Forward Partners is dedicated to nurturing the next generation of leading tech businesses.
Forward.one is a venture capital firm based in Amsterdam, Netherlands, specializing in early-stage investments in European hardware innovations. Their focus areas include semiconductors, climate tech, and high tech, supporting startups from Seed to Series B rounds with initial investments ranging from €250,000 to €5 million, and follow-on investments up to €15 million. The firm has a strong portfolio of innovative companies, such as Sensorfact, an energy efficiency platform, and ROCSYS, which develops automated charging solutions for electric vehicles. Another notable investment is Qualinx, a pioneer in semiconductor technology. Forward.one’s investment strategy is characterized by a commitment to fostering deeptech ventures that address complex problems through technological advancements. Forward.one’s approach goes beyond financial support, offering strategic guidance and leveraging their extensive network to help startups scale effectively. Their team of experienced professionals is dedicated to working closely with entrepreneurs to achieve ambitious goals, exemplifying a hands-on, supportive investment philosophy. With their second fund of €145 million, Forward.one continues to drive innovation in the hardware sector, aiming to make a significant impact on the European tech ecosystem.
oundation Capital, based in Palo Alto, California, is a prominent venture capital firm with a strong track record of backing transformative startups. Founded in 1995, the firm has raised $3.9 billion across 11 funds, supporting companies through various stages of their lifecycle, from seed funding to late-stage ventures. Notable investments by Foundation Capital include Uber, Netflix, Lending Club, and Sunrun, reflecting their strategic focus on high-growth sectors like consumer, information technology, financial technology, and digital energy. The firm is also known for its investments in enterprise software and blockchain technologies, with recent investments in companies like Alation, Algorand, and AltoIRA. Foundation Capital's approach is characterized by high-conviction, high-ownership seed-stage investing, with partners actively involved in guiding startups to success. Key team members include Ashu Garg and Charles Moldow, who bring deep expertise in technology trends and user experiences. The firm has demonstrated a strong commitment to diversity, having made 93 diversity investments to date. Their latest diversity investment was in Gable, which raised $16 million, underscoring their dedication to fostering an inclusive startup ecosystem. For entrepreneurs, Foundation Capital values innovative ideas with the potential to disrupt markets and transform industries. They prefer founders who are prepared to engage deeply, offering robust support and strategic guidance to help their portfolio companies thrive.
Founder Collective, established in 2009, is a venture capital firm based in Cambridge, Massachusetts, with an additional office in New York City. The firm is dedicated to seed-stage investments, partnering with entrepreneurs from the idea phase through to IPO. The founders, including David Frankel, Eric Paley, and Micah Rosenbloom, have all successfully built and sold technology companies, bringing hands-on entrepreneurial experience to their investments. Founder Collective prides itself on being highly aligned with the interests of the entrepreneurs it backs. The firm emphasizes efficient entrepreneurship, encouraging startups to raise just enough capital to accelerate their growth while maintaining significant ownership. This approach has helped companies like The Trade Desk, which raised only $22.5 million in venture capital before achieving a billion-dollar IPO. The firm's portfolio is diverse, covering industries such as technology, financial software, and human capital services. Notable investments include companies like Embark Veterinary, a dog DNA testing company, and PillPack, an online pharmacy acquired by Amazon. Recently, Founder Collective has been involved in the buyout of Dia&Co and investments in innovative companies like Suno and Cascade. With a mission to be the most aligned seed-stage fund, Founder Collective continues to support visionary founders, helping them navigate the challenges of building successful businesses.
Founders Factory, established in 2015 and headquartered in London, is a prominent venture studio and startup accelerator. The firm is dedicated to building and investing in early-stage companies across various sectors, including fintech, health, climate, and deep technology. Founders Factory partners with exceptional entrepreneurs and leading companies to provide capital, bespoke support, and access to a vast network. Notable investments by Founders Factory include Shop Circle, which raised $120 million in Series A funding for its e-commerce software tools, and Scan.com, which secured $12 million in a Series A round to develop its booking infrastructure for diagnostic scans. Other significant investments include Dronamics, a company focused on ultra-efficient, long-distance cargo drones, and Iris AI, an AI engine for scientific text understanding. Founders Factory has achieved several successful exits, such as Feedr, acquired by Compass Group in 2020, and Honest Health, acquired by Hims & Hers in 2021. Their portfolio also includes innovative companies like Fundamental VR, which uses virtual reality for surgical training, and Byway, a platform for sustainable, flight-free travel.
Founders Fund, based in San Francisco, is a prominent venture capital firm known for investing in groundbreaking technologies and transformative companies. Established in 2005, the firm has managed around $12 billion in assets. Founders Fund's portfolio includes major names like SpaceX, Palantir, Stripe, Facebook, Airbnb, and Anduril, showcasing their focus on high-impact, technology-driven ventures. The firm invests across all stages and sectors, making it a generalist with a broad geographic focus. Their strategy emphasizes supporting visionary entrepreneurs who aim to create significant, world-changing companies. Founders Fund is known for its founder-friendly approach, providing extensive support while allowing entrepreneurs the freedom to innovate. Key team members include notable figures such as Peter Thiel, Ken Howery, and Sean Parker, all of whom bring extensive experience from leading successful tech companies like PayPal and Facebook (Wikipedia). The firm’s diverse team and extensive network contribute to its strong reputation in the venture capital space. Startups looking to connect with Founders Fund should demonstrate a clear vision for disrupting existing industries and creating long-term value. The firm’s broad investment strategy and substantial resources make it a critical player in the startup ecosystem.
Founders Future, established in 2018 and headquartered in Paris, France, is a venture capital firm dedicated to supporting visionary entrepreneurs across a variety of sectors. The firm primarily focuses on early-stage investments, including seed and Series A rounds. Founders Future has a robust portfolio with 148 investments and 21 successful exits to date. Some of the notable investments include Omi, a multimedia and design software company, Veeton, and 900.care, which specializes in personal products. The firm is led by Marc Menasé, who is the founding partner, and supported by a dedicated team including Matthieu Benkerant, the Chief Operating Officer, and Sophie Duval, the Partner & General Counsel. Founders Future emphasizes a mission-driven approach, supporting startups that challenge the status quo and have the potential for multi-generational impact. They invest across various industries, from software and fintech to personal products and environmental services. The firm's strategy includes continued financing throughout the venture lifecycle, ensuring startups receive the support they need as they grow and evolve. This approach, combined with their extensive network and expertise, makes Founders Future a valuable partner for early-stage companies looking to make a significant impact.
FoundersX Ventures, established in 2016, is a venture capital firm based in Menlo Park, California, with additional offices in Cambridge, Massachusetts. The firm focuses on building AI-powered digital infrastructure across various industries, including deep tech, enterprise AI, fintech, digital health, and techbio. FoundersX Ventures aims to be the first venture capital partner for pioneering tech founders, leveraging deep-dive research and strong value-added services such as access to top talent and strategic enterprise networks. The team is composed of experienced professionals and advisors deeply rooted in Silicon Valley and connected to leading academic institutions like Stanford, Berkeley, Harvard, and MIT. The leadership includes Managing Partner Helen Liang, PhD, and partners such as Tom Kosnik, PhD, and Leo Cui, PhD, among others. They bring extensive expertise in technology ventures, global marketing, CRISPR research, and bioengineering. FoundersX Ventures has a diverse portfolio of high-growth companies, including notable investments in SpaceX, Salt Security, Jeeves, Rain AI, 1910 Genetics, Universal Quantum, Kernal Bio, Meru Health, and Cognito Therapeutics. The firm's investment strategy emphasizes supporting daring entrepreneurs who are shaping the future and breaking barriers in their respective fields. By backing founders with bold visions and innovative solutions, FoundersX Ventures aims to drive substantial value creation in the next decades, particularly in sectors that leverage AI and advanced technologies to address significant global challenges.
Foundry Group, based in Boulder, Colorado, is a venture capital firm known for its early-stage investments in technology startups. Founded in 2007, the firm operates with a "give first" philosophy, promoting a culture of reciprocity and support within its extensive network of portfolio companies, general partners, and limited partners. The firm focuses on sectors such as SaaS, cybersecurity, developer tools, IoT, fintech, and AI/ML, investing primarily at the pre-seed, seed, and Series A stages. Foundry Group is known for its thematic investment approach, targeting underlying technology protocols and emerging market trends that have the potential to drive significant innovation. Foundry Group's unique network-driven venture capital model fosters close collaboration among its investments, creating a community where resources, knowledge, and opportunities are shared to enhance overall value and success. This approach underscores their commitment to long-term thinking and mutual support, making them a pivotal player in the venture capital landscape.
Future Health Partners, headquartered in New York, is a leading venture capital firm dedicated to advancing innovations in healthcare technology. They focus on a diverse range of sectors, including HealthTech, biotech, MedTech, and healthcare IT, aiming to support companies that streamline healthcare delivery and improve patient outcomes. The firm's notable investments include leading health data analytics platforms and cybersecurity solutions tailored for healthcare, reflecting their emphasis on both operational efficiency and regulatory compliance. Recent investments highlight their commitment to digital health platforms and telehealth solutions, fostering advancements in remote patient monitoring and virtual care delivery. Future Health Partners typically invests in early to growth-stage companies, with investment rounds often ranging from Series A to Series C. They prefer to lead rounds, bringing not just capital but strategic guidance and operational expertise to their portfolio companies. Their geographic focus spans North America, Europe, and increasingly, APAC regions. The team at Future Health Partners comprises seasoned professionals with deep expertise in healthcare and technology sectors. They are proactive in seeking out startups that demonstrate strong leadership and innovative approaches to healthcare challenges. For startups looking to engage with Future Health Partners, it is essential to showcase a strong technological foundation and a clear path to improving healthcare delivery and patient experience. The firm values a well-defined business model and scalability potential, making it crucial for potential investments to align with these strategic priorities.
Four Acres Capital, based in New York, is an early-stage venture fund focused on software-first technology startups. Led by Jenny Friedman, an energetic and well-connected figure in the NYC tech scene, Four Acres targets pre-seed and seed investments in sectors such as business productivity software, healthcare tech, and enterprise systems. The firm values founders with technical prowess, business acumen, and relentless drive. Notable investments include Assort Health, Breadboard, and Reffie, which reflect their focus on innovation in automation, workflow, and enterprise solutions. Four Acres Capital takes a hands-on approach, offering extensive post-investment support and leveraging a robust network of corporate and institutional partners. They often lead rounds, providing both capital and strategic guidance to help founders scale rapidly. By fostering long-term relationships, they remain a dedicated partner as companies grow and evolve. Their connection-focused strategy is evident through curated networking events that help founders access later-stage capital and key partnerships. Friedman, known as the "Cardi B of VC" for her bold, vibrant personality, brings significant experience from her previous roles at Eniac Ventures and Goldman Sachs. Her deep involvement in the New York venture ecosystem has made Four Acres a go-to partner for founders looking for a firm that combines hustle, authenticity, and a strong commitment to growth.
FPV Ventures is a venture capital firm based in San Francisco that focuses on investing in mission-driven founders who are deeply committed to making a long-term impact. Founded by Wesley Chan and Pegah Ebrahimi, FPV Ventures aims to support entrepreneurs who are driven by purpose rather than just profit. The firm backs companies across various sectors, including life sciences, healthcare, financial services, and consumer products. FPV Ventures is particularly interested in early-stage companies, providing them with the necessary resources to scale and succeed. Some of their notable investments include Canva, Guild, and Flexport—companies that are recognized for their innovative approaches and significant contributions to their respective industries. The firm’s philosophy is centered around being the first call for founders, offering not just financial backing but also strategic guidance and support throughout the company’s journey. FPV Ventures manages funds on behalf of various cause-driven organizations, such as universities and hospitals, which align with their mission to create meaningful, long-lasting change. Their investment approach is highly selective, focusing on founders who are often seen as visionaries and are committed to their mission even in the face of challenges.
Frazier Healthcare Partners is a leading private equity and venture capital firm that focuses exclusively on the healthcare sector. Established in 1991, the firm has raised over $7.1 billion in total capital and invested in more than 200 companies. Frazier Healthcare operates through two primary divisions: Growth Buyout and Life Sciences. The Growth Buyout division invests in profitable U.S. middle-market healthcare businesses, providing capital for growth and transformation. The Life Sciences division focuses on private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. Recent notable exits include ARMO BioSciences (acquired by Eli Lilly) and Translate Bio (acquired by Sanofi). Frazier Healthcare Partners is headquartered in Menlo Park, California, with additional offices in Seattle, Washington. The firm's team comprises seasoned professionals with deep industry expertise, including Managing Partners Albert Cha, Patrick Heron, and James Topper.
Freeflow Ventures is a venture capital firm founded in 2019, headquartered in Berkeley, California. The firm focuses on investing in early-stage deep tech companies that are working on innovative solutions in the realms of human and planetary health. Their investment strategy centers around science-driven companies, particularly those leveraging artificial intelligence, machine learning, and advanced technologies to create market-disrupting solutions. Freeflow Ventures has a strong connection with prominent scientific communities, including Caltech and the Jet Propulsion Laboratory (JPL), and is known for providing extensive support to its portfolio companies beyond just capital. This includes assistance in areas such as fundraising, marketing, strategy, and team building, helping startups transition from lab-based research to commercial success. The firm manages three funds, totaling $90 million in assets under management, and has invested in over 30 companies across various sectors, including therapeutics, diagnostics, carbon capture, and advanced manufacturing. Their mission is to support the growth of high-potential startups that are poised to make significant impacts on global health and environmental challenges.
Freestyle Capital, established in 2009 and based in San Francisco, is an early-stage venture capital firm focusing on technology startups. Led by General Partners David Samuel and Jenny Lefcourt, the firm leverages extensive entrepreneurial and operational experience to support its portfolio companies. Freestyle Capital typically invests in startups raising between $1.5 million and $4 million, often leading the seed round. Notable investments include Airtable, Patreon, BetterUp, and Intercom, showcasing the firm’s ability to identify and nurture high-potential startups. The firm is committed to backing passionate founders, providing not only capital but also hands-on guidance and strategic advice. Freestyle Capital emphasizes building strong, supportive relationships with founders, helping them navigate the challenges of scaling their businesses. By combining their deep industry knowledge with a founder-friendly approach, Freestyle Capital has established itself as a valuable partner for early-stage technology companies looking to make a significant impact.
Freigeist Capital, founded in 2009 by Frank Thelen, Marc Sieberger, Marcel Vogler, and Alex Koch, is a Bonn-based venture capital firm specializing in seed investments in deep tech startups across Europe. They focus on sectors like aerospace, AI, automation, biotechnology, clean energy, and robotics. Notable investments by Freigeist Capital include Lilium, an all-electric regional air mobility service; EnduroSat, a provider of nano-satellites for data services; and Kraftblock, which develops scalable thermal energy storage solutions. Other significant investments include Xentral, an ERP software for e-commerce businesses, and RobCo, which creates modular industrial robots. Freigeist Capital is known for its hands-on approach, offering comprehensive support beyond capital, including help with product development, business strategy, and scaling operations. They invest their own money, allowing for quick decision-making and long-term commitment without pressure for quick exits.
Frist Cressey Ventures, founded in 2016 by Senator Bill Frist, M.D., and Bryan Cressey, is a venture capital firm focused on improving healthcare through strategic investments in innovative healthcare solutions. The firm, based in Nashville, Tennessee, invests in early and growth-stage companies that aim to enhance patient outcomes, reduce healthcare costs, and improve the overall healthcare system. Frist Cressey Ventures has a diverse portfolio with notable investments in companies such as ObjectiveHealth, which integrates clinical research into physician practices to improve care quality and access, and Vim, a platform aimed at improving healthcare connectivity and efficiency. Their approach combines financial support with strategic guidance, leveraging their deep industry connections to foster innovation and drive systemic change in healthcare. The leadership team includes experienced professionals like Derek Dedeker, Principal, and Chloe Coulter, Senior Associate, who bring significant expertise from backgrounds in investment banking and healthcare consulting.
Frontcourt Ventures is the venture investment arm of Frontcourt Group, an investment bank and consulting firm founded in 2013 by Robert Sawicki and headquartered in Basking Ridge, New Jersey. Frontcourt Group's primary business is mergers and acquisitions advisory, capital raising, business valuations, financial modeling, strategic planning, and recapitalization services for emerging-growth and middle-market companies. The venture arm channels capital sourced from exclusive investment vehicles backed by large family offices, prominent industry executives, and high-net-worth individuals into equity positions within healthcare and technology companies. Frontcourt Capital, the venture vehicle, targets healthcare-focused companies including medical technology, pharmaceuticals, and healthcare services, investing at Series A and Series B stages. The venture activity is opportunistic rather than programmatic, with investments identified through the firm's advisory relationships rather than from a dedicated fund with a fixed deployment schedule. The only publicly documented portfolio investment is Aria CV, a medical device company focused on pulmonary arterial hypertension, backed as part of a Series B round in January 2020. Frontcourt's model integrates investment activity with advisory services: portfolio companies receive not only equity capital but also the firm's corporate finance expertise, governance support, and access to the executive and family office networks that back Frontcourt Capital. This alignment of advisory and investment interests gives Frontcourt a differentiated role in the healthcare and technology middle market, though the venture activity has been limited in volume relative to the broader advisory business.
Frontline Ventures, founded in 2012, is a venture capital firm with a focus on early-stage and growth-stage investments in B2B software companies. Based in Dublin, Ireland, and with additional offices in London and San Francisco, Frontline Ventures aims to support globally ambitious startups on both sides of the Atlantic. Frontline's notable investments include Workvivo, which was later acquired by Zoom, and Pointy, which was acquired by Google. Other significant investments are in companies like Signal AI, a platform providing real-time insights for media monitoring, and MosaicML, which offers managed infrastructure and tools for training machine learning models. The firm manages two primary funds: Frontline Seed and Frontline Growth. Frontline Seed targets early-stage European startups, helping them navigate their initial growth phases and set the foundation for successful Series A rounds and beyond. Frontline Growth, on the other hand, focuses on scaling established companies and facilitating their entry into the US market, leveraging Frontline's extensive network and expertise. Frontline Ventures places a strong emphasis on supporting companies with potential for significant impact and growth, often aiming to guide them towards eventual public listings. This strategic approach helps ensure that the startups they back are not only innovative but also positioned for long-term success. Frontline Ventures' commitment to fostering innovation and supporting ambitious founders has established it as a key player in the venture capital landscape, particularly within the European and transatlantic startup ecosystems.
FTW Ventures is an early-stage venture capital firm based in San Francisco, focused on revolutionizing the global food system through technology. The firm invests in innovative startups that address critical challenges in food and agriculture technology, including areas like AgTech, advanced materials, supply chain solutions, and biotech. Their mission is to build a better, more sustainable world by supporting the smartest minds tackling these pressing issues. Founded by Brian Frank, FTW Ventures is known for its "problem-focused" investment approach, which seeks out companies that are not only technologically advanced but also capable of making a significant impact on the environment and society. The firm is particularly interested in startups that can transform how food is produced, distributed, and consumed, making the food system more resilient, sustainable, and efficient. FTW Ventures typically leads or co-leads seed and Series A rounds, offering both financial support and strategic guidance. The firm prides itself on being deeply involved with its portfolio companies, helping them navigate the complexities of scaling their businesses while staying true to their mission of creating a positive impact. Some of their notable investments include companies in food robotics, alternative proteins, and sustainable packaging solutions. For entrepreneurs aiming to partner with FTW Ventures, the firm looks for innovative solutions with the potential to disrupt the food and agriculture sectors and create long-lasting change.
Fuel Capital is a venture capital firm founded in 2013 that focuses on early-stage investments in developer tools, business software, and consumer marketplaces. The firm has raised a total of $146 million across three funds, with the latest Fund III closing at $75 million. Fuel Capital's mission is to support founders by providing not just capital but also marketing and branding expertise to help companies grow and succeed. The portfolio includes notable investments in companies like Katerra, Flexport, Convoy, Mesosphere, Clearbit, CTRL-Labs, Figma, Lattice, Nervana (acquired by Intel), and CoreOS (acquired by RedHat). The firm is committed to being a long-term partner to its portfolio companies, focusing on both their professional and personal success. This includes initiatives like the "ReFUEL" series, which supports founders' mental and physical well-being. The leadership team at Fuel Capital includes Managing Partners Chris Howard and Leah Busque Solivan. Chris brings a decade-long career in marketing and branding, while Leah is known for building TaskRabbit into a globally recognized consumer brand. Together, they leverage their experience to offer practical and actionable support to their portfolio companies.
Fund+ is a Belgian venture capital firm that focuses on long-term equity investments in innovative life sciences companies. Established in 2015, the firm aims to create both financial returns and a positive societal impact, primarily investing in therapeutics, diagnostics, and medical devices. Fund+ seeks to address unmet medical needs, with a patient-centric approach. The firm typically invests between €5 million and €15 million per project and plays an active role in its portfolio companies, often taking a seat on the board to provide strategic guidance. With over €200 million in assets under management, Fund+ has built a strong track record, investing in 13 high-potential companies, with two notable exits. The firm's portfolio includes companies such as Indigo Diabetes, which is developing a revolutionary invisible glucose monitoring device, and ExeVir Bio, which focuses on antiviral nanobody treatments for global viral threats. Fund+ also supports companies like Novadip Biosciences, which is developing advanced tissue regeneration therapies, and Confo Therapeutics, known for its groundbreaking GPCR-targeted drug discovery platform. Fund+ operates with a long-term vision, aiming to bolster the life sciences ecosystem in Belgium while fostering innovations that improve patient outcomes globally. Its diverse portfolio reflects a commitment to supporting groundbreaking scientific advancements that have the potential to transform healthcare.
FundersClub, founded in 2012, is the world's first online venture capital platform, revolutionizing how investments in startups are made. This San Francisco-based firm offers accredited investors the opportunity to invest in highly vetted early-stage and growth-stage technology startups through an online platform. FundersClub has backed notable companies like Coinbase, Instacart, GitLab, and Flexport, among others. The platform employs a rigorous vetting process, reviewing thousands of startups and selecting fewer than 2% for investment. This selection process involves initial reviews, internal investment committee evaluations, and feedback from a panel of over 270 experienced startup professionals. FundersClub has facilitated over $183 million in investments across more than 370 startups, which have collectively raised over $6 billion in follow-on capital. The portfolio is currently valued at more than $30 billion. In addition to funding, FundersClub provides hands-on support to its portfolio companies, helping them with customer acquisition, team building, and subsequent fundraising efforts. The firm leverages its extensive network and proprietary software tools to offer continuous assistance to founders throughout their startup journey.
Fusion Fund, led by Lu Zhang, is a Palo Alto-based venture capital firm focusing on early-stage investments in North America. Their portfolio includes notable startups like You.com, Vectara, and GrubMarket, which highlight their strength in deep tech, AI, and healthcare. They predominantly invest in pre-seed, seed, and Series A rounds, targeting sectors such as healthcare technology, enterprise AI, and industrial automation. Fusion Fund’s investment strategy centers on leveraging technical and data advantages to back founders with deep expertise in their fields. They seek entrepreneurs who are not only innovative but also demonstrate strong execution capabilities. The fund is known for its active involvement in its portfolio companies, providing critical market validation and support to build solid revenue pipelines. Their team, composed of seasoned professionals with extensive technical and operational backgrounds, is dedicated to helping startups navigate the complexities of early-stage growth. Zhang’s journey from a startup founder to a leading VC highlights the fund’s commitment to fostering innovation and resilience among founders. Fusion Fund prefers to lead rounds and often co-invests with larger VCs. They look for startups with high growth potential and are particularly interested in those harnessing AI and advanced data analytics to solve complex problems. Entrepreneurs can approach Fusion Fund through their structured fellowship programs or by directly engaging with their team during industry events. With over $215.5 million raised across three funds, Fusion Fund remains a pivotal player in supporting the next wave of technological advancements.
FusionX Ventures is a Southern California-based venture capital firm that specializes in early-stage investments, particularly in technology, industrial, and medical/life sciences sectors. The firm is known for its hands-on approach, leveraging its team's extensive entrepreneurial and operational experience to support portfolio companies. FusionX Ventures invests in startups that create innovative solutions at the intersection of hardware, software, and cloud technologies. The firm typically invests during the Seed and Series A stages, focusing on companies that offer recurring revenue models. FusionX's investment strategy is centered around contributing strategic value, particularly in areas like design, manufacturing, and go-to-market strategies. Their portfolio includes a variety of companies across industries such as health tech, robotics, fintech, and more, aiming to help these startups grow into market leaders. FusionX Ventures is also distinguished by its founders' deep experience in building, growing, and exiting their own venture-backed businesses, which they bring to bear in helping other entrepreneurs succeed.
Future Africa is a venture capital firm focused on funding and supporting African startups addressing the continent's most pressing challenges. Founded by Iyinoluwa Aboyeji, the firm has invested in a variety of sectors including fintech, healthtech, and edtech. Some of their notable portfolio companies include Flutterwave, Andela, and Moove. Future Africa typically makes seed-stage investments ranging from $100,000 to $500,000, and provides significant follow-on capital. They emphasize a community-driven approach, leveraging a network of over 300 founders, investors, and advisors to support their portfolio companies from the ground up. This network helps provide strategic advice, introductions, and support critical for early-stage growth. The firm has a strong focus on talent, infrastructure, markets, and the environment, aiming to build sustainable and scalable businesses across Africa. They have a proven track record with over $10 million deployed, more than 100 portfolio companies, and successful exits including Flutterwave and Andela, both of which have achieved unicorn status.
First Ever Ventures (FEV), also known as UVF, is a venture capital firm focused on impactful investing. Established with the mission to do good while doing well, FEV has a diversified portfolio that spans various sectors. They prioritize investments in innovative companies that aim to generate significant social and environmental impact while achieving substantial financial returns. Their notable investments include companies like Recycleye, which provides AI-powered recycling technology; Edovo, an education technology company focused on providing quality education to incarcerated individuals; and GoReact, a video assessment platform for skills-based learning. These investments highlight FEV's commitment to supporting ventures that offer transformative solutions in their respective fields. First Ever Ventures is structured around a unique investment model that leverages the involvement of motivated students and experienced professionals to deploy catalytic capital, primarily in the Intermountain West and beyond. This model not only supports high-impact startups but also contributes to the development of future leaders in venture capital and social entrepreneurship.
Future Food Fund is a Dutch venture capital firm dedicated to driving sustainability within the food and agriculture sector. Established in 2017, the fund focuses on early-stage investments, particularly in companies that are innovating across the food value chain. Their areas of interest include regenerative agriculture, alternative proteins, smart farming, and circular food systems. Future Food Fund seeks to support startups that can address critical environmental challenges and contribute to building a sustainable food ecosystem. Recently, Future Food Fund II, their second impact-driven fund, successfully raised €40 million. Backed by notable partners such as the European Investment Fund (EIF) and regional organizations like Wageningen University & Research, Oost NL, and NOM, the fund aims to accelerate early-stage agritech and food startups across Western Europe. The firm positions itself as more than just a source of capital; it is seen as a catalyst for change, fostering innovation that can mitigate the environmental footprint of current food systems. Their portfolio includes startups such as NoPalm Ingredients and Pectcof, focusing on sustainable ingredient production, and EV Biotech, which works on precision fermentation. With a strong network of partners, Future Food Fund emphasizes collaborative growth, providing both capital and strategic support to ensure startups can scale effectively and deliver impactful solutions.
Future Planet Capital, based in London, is an impact-led venture capital firm that focuses on investing in high-growth companies addressing global challenges. The firm manages over $400 million in assets and has deployed an additional $200 million through co-investment initiatives. Their investment strategy aligns with the UN Sustainable Development Goals, targeting sectors such as climate change, health, education, security, and sustainable growth. Notable investments by Future Planet Capital include companies like 23andMe, Clarivate Analytics, and Vaccitech, which played a significant role in developing the Oxford-AstraZeneca COVID-19 vaccine. The firm has been instrumental in supporting innovations from top universities and research ecosystems globally, leveraging a data-driven approach to systematically score and benchmark the world's most innovative companies. Future Planet Capital's portfolio includes over 140 companies across various stages and geographies, focusing on impactful solutions like Tokamak Energy for sustainable energy, Captura for carbon removal, and Barinthus Biotherapeutics for advanced vaccines and immunotherapies. The firm is known for its commitment to fostering sustainable and profitable growth through strategic partnerships and deep industry expertise. The firm is led by a seasoned team of professionals, including co-founder and Executive Chairman Douglas Hansen-Luke, who bring a wealth of knowledge in science, innovation, and investment to support and scale their portfolio companies effectively.
Future Positive Capital is a Paris-based venture capital firm focused on driving large-scale solutions to universal challenges. With a strategy centered on sustainability and advanced technology, the firm invests primarily in seed and Series A stages, committing between €500K to €3M. Future Positive targets sectors like climate tech, health tech, robotics, and biotech, and has backed notable companies such as Ouihelp, Brilliant Planet, and Sweetch Energy. Their portfolio spans innovative companies addressing global issues, from restoring ecosystems to improving supply chain transparency. The fund’s investment thesis emphasizes a holistic approach to value creation, blending business growth with technological and societal impact. They lead or co-lead rounds, prioritizing companies that offer groundbreaking solutions—like a 100x improvement on existing technologies—and have a proven product-market fit. Future Positive actively engages with founders, aligning their long-term incentives with both financial success and measurable societal impact. Co-founded by Sofia Hmich, the firm is deeply rooted in Europe, particularly in France and the UK, but looks for scalable global solutions. Startups are encouraged to approach Future Positive if they’re tackling urgent problems with innovative, validated technology and a bold vision for the future.
Future Positive Capital is a Paris-based venture capital firm that focuses on investing in advanced technology companies that address global challenges at a planetary scale. The fund emphasizes sustainable innovation and supports entrepreneurs who are driving systemic changes in sectors like health tech, green energy, robotics, and more. Notable investments include Ouihelp, Brilliant Planet, Circulor, and Aerones, companies that lead in areas such as elderly care, renewable energy, and biodiversity restoration. Founded in 2016, Future Positive Capital typically invests in Series A to C stages, with check sizes ranging from €500,000 to €3 million. Their investment thesis revolves around fostering long-term societal, technological, and environmental impact. The firm places a strong emphasis on backing entrepreneurs whose innovations have the potential for large-scale societal progress, and it leads or co-leads many of the funding rounds it participates in. Sofia Hmich, the co-founder and managing partner, leads the firm alongside a dedicated team. With a clear mission to shape preferable futures, Future Positive Capital builds close partnerships with startups, providing both capital and strategic support to help them scale
Future Shape LLC is an investment and advisory firm founded by Tony Fadell, known for his work at Apple and Nest Labs. Based in Paris, France, the firm focuses on deep technology, investing in engineers and scientists developing groundbreaking technologies. Founded in 2014, Future Shape primarily engages in seed investments but is also involved in later-stage funding under specific conditions. The firm's investment portfolio spans multiple sectors, including agriculture, energy, transportation, medical diagnostics, financial services, consumer products, and robotics. Notable investments include companies like Phononic, Modern Meadow, Weave, Simbe Robotics, and Vium. Future Shape is known for its hands-on approach, providing not just capital but also strategic guidance in areas such as product-to-market fit, branding, user experience, and go-to-market strategies. Future Shape typically invests amounts ranging from $100K to $10M, with a focus on early-stage companies in the US and Europe, though it occasionally invests in Asia and the Middle East. The firm's approach integrates extensive collaboration and advisory services, helping startups navigate the complexities of commercialization and scale their innovations effectively. Led by Tony Fadell, Future Shape leverages his extensive experience and network to support the growth and success of its portfolio companies, making it a key player in the venture capital landscape for deep tech startups.
Future Ventures, founded by Steve Jurvetson and Maryanna Saenko, focuses on seed and early-stage investments in transformative technologies. The firm invests in trailblazing, purpose-driven entrepreneurs with the potential to reinvent entire industries. Notable investments include companies such as SpaceX, Tesla, Upside Foods, and The Boring Company. Future Ventures targets sectors like AI, synthetic biology, sustainable transportation, and space exploration. Their strategy involves deep involvement with their portfolio companies, often leading founding investments and joining their boards. Steve Jurvetson, a prominent figure in venture capital, has a history of backing groundbreaking companies. Maryanna Saenko brings expertise from her previous roles at Khosla Ventures and Airbus Ventures, focusing on frontier technologies that make a significant impact on society.
FuturePlay, based in South Korea, is a venture capital firm and startup incubator founded in 2014. The firm focuses on early-stage investments in sectors such as healthtech, robotics, and AI, with a particular emphasis on companies that leverage advanced technology to create innovative solutions. Notable investments by FuturePlay include ThePlantEAT, a platform for plant-based diet recommendations, and Mimetics, a company specializing in robotic process automation. The firm has also backed companies like Anchor Node, which focuses on AI-driven knowledge management, and Toggle Insurance Service, a digital insurance platform. FuturePlay has achieved successful exits with companies like Noul, which went public on the Korea Exchange in 2022, and Vuno, a medical AI startup that also had an IPO in 2021. Additionally, FuturePlay has seen several of its portfolio companies acquired, including Sennen, which was acquired by Kraken in 2023. The firm is known for its hands-on approach, providing extensive support to startups through their incubation programs and helping them scale through strategic partnerships and access to a robust network of co-investors.
G20 Ventures is a Boston-based venture capital firm that focuses on early-stage investments, particularly in enterprise software and Web3 technologies. Founded in 2013, G20 Ventures prides itself on taking a "people-first" approach, emphasizing human relationships and community support over scaling its own business. The firm is well-known for its hands-on involvement with entrepreneurs, offering not just capital but also strategic guidance, storytelling expertise, and key connections to help startups grow effectively. The firm typically invests between $2 to $5 million in Series A rounds but is also open to earlier-stage investments, particularly in emerging technologies. Their portfolio includes innovative companies like CloudZero, Fetcher, and RippleMatch, all of which reflect their focus on tech-driven solutions that can have a transformative impact. With deep ties to the East Coast, G20 Ventures leverages its local network to provide significant value to its portfolio companies, but its investments span across various sectors and geographies. The team at G20 includes seasoned professionals like co-founders Bob Hower and Bill Wiberg, both of whom bring decades of venture capital and entrepreneurial experience to the table.
Gaingels is a leading venture investment syndicate championing the LGBT+ community and its allies. Notable investments include BlockFi, Gusto, Lambda School, and Scopely. They focus on a broad range of sectors such as biotech, fintech, e-commerce, and social impact, investing at stages from pre-seed to Series B and beyond. Geographically, Gaingels has a global reach with a strong presence in major startup hubs like San Francisco, New York, and Paris. Their investment strategy is unique, emphasizing diversity and inclusion within their portfolio companies. Gaingels co-invests alongside top venture capital firms, enhancing the social good while driving substantial financial returns. They are known for leading rounds and making substantial contributions with an average check size varying by the investment stage. The fund's approach to building a robust investment funnel involves leveraging their extensive network and prioritizing companies with LGBT+ leadership or a strong commitment to diversity. Founders looking to connect with Gaingels should highlight their dedication to inclusivity and the positive social impact of their ventures. The team is spearheaded by co-founders David Beatty and Paul Grossinger, who bring a wealth of experience and a deep commitment to fostering a more inclusive venture capital ecosystem. Their proactive support and strategic insights have been instrumental in the success of their diverse portfolio. By blending financial acumen with a mission-driven focus, Gaingels stands out as a transformative force in venture capital, paving the way for a more equitable and prosperous future.
GAN Ventures, based in Denver, is a venture capital firm that focuses on investing in global, early-stage companies with high growth potential. As part of the Global Accelerator Network (GAN), the fund is driven by a mission to support founders with integrity, self-awareness, and the ability to scale. GAN Ventures targets a wide range of industries including SaaS, fintech, healthcare, and consumer products, backing startups like Buderflys, CleanRobotics, and Pomp. The firm offers catalytic capital to founders across the world, particularly those who are graduates of GAN’s accelerator programs. With a typical check size of around $100k, GAN Ventures focuses on the pre-seed and seed stages, and they prioritize companies that align with their values of sustainability, innovation, and community impact. Unlike many traditional VCs, GAN Ventures builds close, long-term relationships with founders, helping them through mentorship, resources, and connections within their vast global network. The firm’s co-founders, Patrick Riley and Reilly Flynn, bring deep expertise from their backgrounds at Techstars and various leadership roles in venture-backed companies. GAN Ventures doesn’t just provide financial backing but also helps portfolio companies navigate critical growth phases, ensuring that they are well-equipped to succeed in competitive markets. By leveraging GAN’s global reach, the firm has established a strong presence in regions like North America, Europe, and Africa, supporting companies that create meaningful change in their industries.